---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-122057"
form_type: "8-K"
ticker: "CLRB"
cik: "0001279704"
company_name: "Cellectar Biosciences, Inc."
filed_at: "2023-11-29T23:59:59+00:00"
generated_at: "2026-06-07T20:13:25.936173+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cellectar regains Nasdaq compliance via $35M+ market value of listed securities

## Summary
- Nasdaq notified Cellectar on Nov 21, 2023, that it meets the $35M minimum market value of listed securities under Rule 5550(b)(2), resolving the deficiency.
- Prior deficiency: stockholders' equity was $(467,000) as of June 30, 2023, below the $2.5M minimum required under Rule 5550(b)(1).
- The company had been at risk of delisting since August 16, 2023; compliance is now fully restored.

## SEC filing metadata
- accession: 0001104659-23-122057
- form_type: 8-K
- ticker: CLRB
- cik: 0001279704
- company_name: Cellectar Biosciences, Inc.
- filed_at: 2023-11-29T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1279704/000110465923122057/0001104659-23-122057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1279704/000110465923122057/tm2331790d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-122057
- JSON: https://secwatch.observer/filing/0001104659-23-122057.json
- Plain text: https://secwatch.observer/filing/0001104659-23-122057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.